Case Reports

37-year-old man • cough • increasing shortness of breath • pleuritic chest pain • Dx?

Author and Disclosure Information

 

References

Excavating bronchogenic carcinomas differ from a lung abscess in that a patient with the latter is typically, but not always, febrile and has purulent sputum. On imaging, a bronchogenic carcinoma has a thicker and more irregular wall than a lung abscess.10

Treatment

When antibiotics first became available, penicillin was used to treat lung abscess.11 Then IV clindamycin became the drug of choice after 2 trials demonstrated its superiority to IV penicillin.12,13 More recently, clindamycin alone has fallen out of favor due to growing anaerobic resistance.14

Current therapy includes beta-lactam with beta-lactamase inhibitors.14 Lung abscesses are typically polymicrobial and thus carry different degrees of antibiotic resistance.15,16 If culture data are available, targeted therapy is preferred, especially for secondary abscesses.7 Antibiotic therapy is usually continued until a CXR reveals a small lesion or is clear, which may require several months of outpatient oral antibiotic therapy.4

Visible improvement 1 month after treatment

Our patient was treated with IV clindamycin for 3 days in the hospital. Clindamycin was chosen due to his penicillin allergy and started empirically without any culture data. He was transitioned to oral clindamycin and completed a total 3-week course as his CXR continued to show improvement (FIGURE 3). He did not undergo bronchoscopy. A follow-up CXR showed resolution of lung abscess at 9 months. (FIGURE 4).

Complete radiographic resolution of the lung abscess at 9 months

THE TAKEAWAY

All patients with lung abscesses should have sputum culture with gram stain done—­ideally prior to starting antibiotics.3,4 Bronchoscopy should be considered for patients with atypical presentations or those who fail standard therapy, but may be used in other cases, as well.3

CORRESPONDENCE
Morteza Khodaee, MD, MPH, AFW Clinic, 3055 Roslyn Street, Denver, CO 80238; morteza.khodaee@cuanschutz.edu

Pages

Recommended Reading

Palliative care for patients with dementia: When to refer?
MDedge Family Medicine
ERRATUM
MDedge Family Medicine
Novel Alzheimer’s drug slows cognitive decline in phase 2 trial
MDedge Family Medicine
Despite risks and warnings, CNS polypharmacy is prevalent among patients with dementia
MDedge Family Medicine
Neurologic drug prices jump 50% in five years
MDedge Family Medicine
Type 2 diabetes linked to increased risk for Parkinson’s
MDedge Family Medicine
Prenatal dietary folate not enough to offset AEDs’ effect on kids’ cognition
MDedge Family Medicine
Time is of the essence: DST up for debate again
MDedge Family Medicine
Encephalopathy common, often lethal in hospitalized patients with COVID-19
MDedge Family Medicine
Age-related cognitive decline not inevitable?
MDedge Family Medicine